Pharmaceuticals
EcoSupp listens, learns, and delivers
Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
From Auschwitz to Dachau: How a pharmacist became central to Nazi camp medical crimes - study
Science breakthroughs in space: Israel leads the way
SpacePharma founder Yossi Yamin talks science in no gravity.
CytoReason forms partnership with Helixrus, expanding into Asia
The partnership will see Helixrus represent CytoReason’s AI platform and professional services in the Korean market.
Eight Israeli start-ups to form international collaborations
Following BetterPlayBio’s program, C2i Genomic, Nucle.ai, Medial Earlysign, iBex, Octopus, Imagene, Itamar Medical and iCardio are ready to hit the global market.
Super-Pharm to independently import, sell medical cannabis in Israel
This follows several steps taken in Israel to make the use of medical cannabis more efficient for those who need it.
Saffron Tech partners with Naveh Pharma to create Saffron-based cosmetics
"This partnership aligns both companies' unique strengths," says Saffron Tech CEO Tal Wilk Glazer.
AION Labs: At the forefront of the pharmaceutical revolution
Four times a year, five teams of scientists are invited to Israel for a five-day intensive boot camp, during which they solve a challenge relevant to today’s pharma industry.
Israeli startup CytoReason collaborates with Pfizer on machine learning
CytoReason’s massive database and AI-led platform, biotech companies can identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.
Pharmaceutical company PsyRx announces new Executive Chairman
Grotto also helped in national strategy developments during the coronavirus outbreak in Israel for the first time.
'Pharma bro' Martin Shkreli ordered to pay $64m. to price gouging victims
The FTC and seven states, including New York, sued in January 2020 accusing Vyera Pharmaceuticals — formerly Shkreli’s company Turing — of increasing the price of Daraprim by more than 4,000%.
Pfizer to buy Arena Pharmaceuticals in $6.7 billion deal
Arena's shares soared on the news. They ended trading Friday $49.94 but closed on Monday at $90.08 — an 80 percent gain. Pfizer's shares also were up nearly 5 percent.
